Literature DB >> 17015631

Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.

Fèlix Gilgado1, Carolina Serena, Josep Cano, Josepa Gené, Josep Guarro.   

Abstract

Eighty-four isolates belonging to eight species that constitute the Pseudallescheria boydii complex were tested against 11 antifungal agents by using the microdilution method. There were significant differences among the species, with Scedosporium aurantiacum being the most resistant. In general, voriconazole was the most active drug, followed by posaconazole.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17015631      PMCID： PMC1694014          DOI： 10.1128/AAC.00981-06

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  Treatment of Scedosporium apiospermum brain abscesses with posaconazole.

Authors:  Ingo K Mellinghoff; Drew J Winston; Geoffrey Mukwaya; Gary J Schiller
Journal:  Clin Infect Dis       Date:  2002-05-16       Impact factor: 9.079

2.  Infection of the CNS by Scedosporium apiospermum after near drowning. Report of a fatal case and analysis of its confounding factors.

Authors:  P A Kowacs; C E Soares Silvado; S Monteiro de Almeida; M Ramos; K Abrão; L E Madaloso; R L Pinheiro; L C Werneck
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

3.  In vitro activities of four novel triazoles against Scedosporium spp.

Authors:  A J Carrillo; J Guarro
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

4.  Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.

Authors:  M Cuenca-Estrella; B Ruiz-Díez; J V Martínez-Suárez; A Monzón; J L Rodríguez-Tudela
Journal:  J Antimicrob Chemother       Date:  1999-01       Impact factor: 5.790

5.  Scedosporium apiospermum mycetoma with bone involvement successfully treated with voriconazole.

Authors:  L Porte; S Khatibi; L El Hajj; S Cassaing; A Berry; P Massip; M D Linas; J F Magnaval; N Sans; B Marchou
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-05-22       Impact factor: 2.184

6.  Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus.

Authors:  S Arunmozhi Balajee; Jennifer L Gribskov; Edward Hanley; David Nickle; Kieren A Marr
Journal:  Eukaryot Cell       Date:  2005-03

7.  Correlation between in vitro susceptibility of Scedosporium apiospermum to voriconazole and in vivo outcome of scedosporiosis in guinea pigs.

Authors:  Javier Capilla; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

8.  Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice.

Authors:  Javier Capilla; Carolina Serena; F Javier Pastor; Montserrat Ortoneda; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

9.  Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii.

Authors:  T J Walsh; J Peter; D A McGough; A W Fothergill; M G Rinaldi; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

10.  Flucytosine resistance is restricted to a single genetic clade of Candida albicans.

Authors:  Claude Pujol; Michael A Pfaller; David R Soll
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191
View more
  42 in total

1.  Scopulariopsis, a poorly known opportunistic fungus: spectrum of species in clinical samples and in vitro responses to antifungal drugs.

Authors:  Marcelo Sandoval-Denis; Deanna A Sutton; Annette W Fothergill; Josep Cano-Lira; Josepa Gené; C A Decock; G S de Hoog; Josep Guarro
Journal:  J Clin Microbiol       Date:  2013-09-11       Impact factor: 5.948

Review 2.  Pharmacokinetic/pharmacodynamic profile of posaconazole.

Authors:  Yanjun Li; Ursula Theuretzbacher; Cornelius J Clancy; M Hong Nguyen; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2010-06       Impact factor: 6.447

3.  Evaluation of the Vitek MS Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry System for Identification of Clinically Relevant Filamentous Fungi.

Authors:  Allison R McMullen; Meghan A Wallace; David H Pincus; Kathy Wilkey; C A Burnham
Journal:  J Clin Microbiol       Date:  2016-05-25       Impact factor: 5.948

4.  Effects of Photodynamic Therapy on the Growth and Antifungal Susceptibility of Scedosporium and Lomentospora spp.

Authors:  Qiaoyun Lu; Yi Sun; Dingdan Tian; Shoubao Xiang; Lujuan Gao
Journal:  Mycopathologia       Date:  2017-08-23       Impact factor: 2.574

5.  Experimental murine scedosporiosis: histopathology and azole treatment.

Authors:  M Mar Rodríguez; F Javier Pastor; Valentina Salas; Enrique Calvo; Emilio Mayayo; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

Review 6.  Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections.

Authors:  Emily Zoller; Connie Valente; Kyle Baker; Michael E Klepser
Journal:  Drug Des Devel Ther       Date:  2010-11-04       Impact factor: 4.162

Review 7.  Fungus-Specific CD4 T Cells as Specific Sensors for Identification of Pulmonary Fungal Infections.

Authors:  Alexander Scheffold; Carsten Schwarz; Petra Bacher
Journal:  Mycopathologia       Date:  2017-11-22       Impact factor: 2.574

8.  Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii.

Authors:  Fèlix Gilgado; Josep Cano; Josepa Gené; Deanna A Sutton; Josep Guarro
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

9.  In vitro antifungal susceptibilities of five species of sporothrix.

Authors:  Rita Marimon; Carolina Serena; Josepa Gené; Josep Cano; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2007-11-26       Impact factor: 5.191

10.  Molecular typing of Australian Scedosporium isolates showing genetic variability and numerous S. aurantiacum.

Authors:  Laurence Delhaes; Azian Harun; Sharon C A Chen; Quoc Nguyen; Monica Slavin; Christopher H Heath; Krystyna Maszewska; Catriona Halliday; Vincent Robert; Tania C Sorrell; Wieland Meyer
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.